Shakti Polytarp IPO GMP

Listed

Shakti Polytarp IPO GMP & Listing Price

SME · ₹59 · 2000 shares/lot · BSE SME

Final GMP before listing
₹6+10.2%
▲ ₹5 since last reading
22 Sept, 3:37 pm
IST

Range so far: ₹5 low · ₹6 high

17 Sept22 Sept
Listed at
₹58.9
Listing gain / lot
-₹200
Cost / lot
₹1,18,000

GMP vs actual listing

GMP implied
+10.2%
Listed at
₹58.9
Actual
-0.2%

Closed its first day at ₹57.08 (-3.3% on the issue price)

Shakti Polytarp carried a grey market premium of ₹6 on an issue price of ₹59, implying a listing around ₹65 (+10.2%). It opened at ₹58.9, -0.2% — 10.3 points below what the grey market implied.

The premium shown is the one published here before listing, frozen at the bell and never revised afterwards. See all 208 calls, including the misses.

Timeline

  1. Opens
    15 Sept
  2. Closes
    17 Sept
  3. Allotment
    18 Sept
  4. Listing
    22 Sept

Subscription status

as of 22 Sept, 3:37 pm
Total11.87x
Issue typeSME
Incorporated2018
SectorPackaging
Price₹59
Lot size2000 shares
Min investment₹1,18,000
Issue size₹26.93 Cr
P/E ratio7.38
Face value₹10
RegistrarSkyline Financial Services
ISININE05UY01016
Listing atBSE SME
Listing dateTue, 22 Sept, 2026
BSE code544933

Official documents

Shakti Polytarp IPO FAQs

What was the listing price of Shakti Polytarp IPO?

Shakti Polytarp IPO listed at ₹58.9 on Tue, 22 Sept, 2026, -0.2% against the issue price of ₹59, a loss of ₹200 on one lot of 2000 shares. The last grey market premium before listing was ₹6, which implied ₹65.

What was the GMP of Shakti Polytarp IPO before listing?

The last grey market premium for Shakti Polytarp IPO was ₹6, recorded at 3:37 pm IST on Tue, 22 Sept, 2026. That implied +10.2% over the ₹59 price. The stock actually listed -0.2%, so GMP was off by 10.3%.

When was Shakti Polytarp IPO allotment and listing?

Allotment for Shakti Polytarp IPO was finalised on Fri, 18 Sept, 2026 and the shares listed on Tue, 22 Sept, 2026 on BSE SME. The registrar is Skyline Financial Services.

GMP is unofficial. Grey market premium is an unregulated, over-the-counter indication with no backing from SEBI, BSE or NSE. It is not a listing-price guarantee and not investment advice. Read the RHP and consult a SEBI-registered adviser before applying.